Loading...
•
Dec 31, 2019
OrthoPediatrics Q4 2019 Earnings Report
OrthoPediatrics experienced revenue growth and strategic advancements.
Key Takeaways
OrthoPediatrics Corp. reported a strong fourth quarter and full year 2019, marked by a 30.1% increase in Q4 revenue to $19.0 million and a 26.0% increase in full-year revenue to $72.6 million. The company launched new products, expanded its sales organization, and strengthened its cash position through a follow-on offering.
Total revenue increased to $19.0 million, up 30.1% from Q4 2018.
Trauma and Deformity revenue grew by 34%, Scoliosis by 21%, and Sports Medicine/Other by 18%.
Launched PediFoot Deformity Correction System and QuickPack™ bone graft substitute.
Strengthened cash position with $60 million in net proceeds from follow-on offering.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Revenue by Segment
Trauma & Deformity Revenue
CapyFin.comScoliosis Revenue
CapyFin.comSports Medicine/Other Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
OrthoPediatrics provided full year 2020 revenue guidance of growth in the range of 22%-24% and investment in consignment sets to be in a range of $19-$21 million.
Positive Outlook
- Revenue growth in a range of 22% to 24% year-over-year
- Investing $19-$21 million in consigned sets for 2020
- Focus on deploying capital-efficient systems
- Realizing the revenue impact from the full roll-out of recent product launches
- Commitment to pediatric-specific surgical solutions
Revenue & Expenses
Visualization of income flow from segment revenue to net income